Shares of P3 Health Partners were trading at $0.1829 as of March 25. Over the last 52-week period, shares are down 82.58%.

P3 Health Partners' Q4 2024 earnings show 18% annual revenue growth and reaffirmed profitability goals for 2025.

Good day and welcome to the P3 Health Partners’ Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there ...

P3 Health Partners Inc. (PIII) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.22 per share a year ago. These ...

In a challenging market environment, PIII, also known as Foresight Acquisition, has seen its stock price tumble to a 52-week low... ByInvesting.com • Mar 13, 2025 PIII stock plunges to 52-week ...

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient- centered and physician-led population health management company, today announced its financial results for the fourth quarter ...

NEW YORK, March 23 (Reuters) - Rapid7 (RPD.O), opens new tab is nearing a settlement with activist investor Jana Partners after the cybersecurity company and the hedge fund discussed ways to boost ...

March 26, 2025 • As the U.S. health system grapples with new outbreaks and the risk of old diseases making a comeback, we're looking to the past to inform how people in marginalized communities ...